News

The study will evaluate the safety and tolerability of fulvestrant 500mg compared to anastrozole 1mg in 450 postmenopausal patients with hormone receptor-positive advanced breast cancer and those who

The vaccine was manufactured by Chemo-Sero-Therapeutic Research Institute at Kaketsuken. The bulk materials of Kaketsuken’s adsorbed purified pertussis diptheria tetanus combined vaccine (DPT vaccine) and the bulk of

The Conference, which will be held from 8-9 November, will discuss how to avoid risks of patient or material unblinding when defining drug supply specifications of interactive response

Under the agreement, both the companies will be responsible for the development, registration and manufacture of the biosimilar that leverages BioXpress technology. AET BioTech managing director Dr Harm

VAL-083 has received the Chinese State Food and Drug Administration (SFDA) approval as cancer chemotherapy to treat Chronic Myelogenous Leukemia (CML) and lung cancer. The companies are also

The new Leucovorin Calcium for Injection is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, diminish the toxicity and counteract the effects of impaired methotrexate elimination and

The analytical laboratory, which is developed as part of the UK GLP Compliance Monitoring program, provides GLP analysis including mass spectrometry, FT IR and GLP NMR (including capillary

The patent covers the claims related to application No.12/769,885 for the use of Amarin’s product, Vascepa (icosapent ethyl) capsules, as a treatment for hypertriglyceridemia. Amarin chairman and chief

PV-10 is a new oncology drug that selectively targets and destroys cancer cells without harming surrounding healthy tissue, thereby reducing potential for systemic side effects. The data titled